换一批Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.
第一作者：
Mary-Elizabeth,Percival
第一单位：
Division of Hematology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. mperciva@seattlecca.org.
作者：
Mary-Elizabeth,Percival [1]
;
Hai-Lin,Wang [2]
;
Mei-Jie,Zhang [3]
;
Wael,Saber [2]
;
Marcos,de Lima [4]
;
Mark,Litzow [5]
;
Partow,Kebriaei [6]
;
Hisham,Abdel-Azim [7]
;
Kehinde,Adekola [8]
;
Mahmoud,Aljurf [9]
;
Ulrike,Bacher [10]
;
Sherif M,Badawy [11]
;
Amer,Beitinjaneh [12]
;
Nelli,Bejanyan [13]
;
Vijaya,Bhatt [14]
;
Michael,Byrne [15]
;
Jean-Yves,Cahn [16]
;
Paul,Castillo [17]
;
Nelson,Chao [18]
;
Saurabh,Chhabra [19]
;
Edward,Copelan [20]
;
Corey,Cutler [21]
;
Zachariah,DeFilipp [22]
;
Ajoy,Dias [23]
;
Miguel Angel,Diaz [24]
;
Elihu,Estey [25]
;
Nosha,Farhadfar [26]
;
Haydar A,Frangoul [27]
;
César O,Freytes [28]
;
Robert Peter,Gale [29]
;
Siddhartha,Ganguly [30]
;
Lohith,Gowda [31]
;
Michael,Grunwald [20]
;
Nasheed,Hossain [32]
;
Rammurti T,Kamble [33]
;
Christopher G,Kanakry [34]
;
Ankit,Kansagra [35]
;
Mohamed A,Kharfan-Dabaja [36]
;
Maxwell,Krem [37]
;
Hillard M,Lazarus [38]
;
Jong Wook,Lee [39]
;
Jane L,Liesveld [40]
;
Richard,Lin [41]
;
Hongtao,Liu [42]
;
Joseph,McGuirk [43]
;
Reinhold,Munker [44]
;
Hemant S,Murthy [36]
;
Sunita,Nathan [45]
;
Taiga,Nishihori [13]
;
Richard F,Olsson [46]
;
Neil,Palmisiano [47]
;
Jakob R,Passweg [48]
;
Tim,Prestidge [49]
;
Olov,Ringdén [50]
;
David A,Rizzieri [51]
;
Witold B,Rybka [52]
;
Mary Lynn,Savoie [53]
;
Kirk R,Schultz [54]
;
Sachiko,Seo [55]
;
Akshay,Sharma [56]
;
Melhem,Solh [57]
;
Roger,Strair [58]
;
Marjolein,van der Poel [59]
;
Leo F,Verdonck [60]
;
Jean A,Yared [61]
;
Daniel,Weisdorf [62]
;
Brenda M,Sandmaier [63]
作者单位：
Division of Hematology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. mperciva@seattlecca.org.
[1]
CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
[2]
CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.;Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA.
[3]
Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
[4]
Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN, USA.
[5]
Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[6]
Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
[7]
Division of Hematology and Oncology, Department of Medicine and Robert H. Lurie Comprehensive Cancer, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
[8]
Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
[9]
Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
[10]
Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.;Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
[11]
University of Miami, Miami, FL, USA.
[12]
Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.
[13]
The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
[14]
Vanderbilt University Medical Center, Nashville, TN, USA.
[15]
Department of Hematology, CHU Grenoble Alpes, Grenoble, France.
[16]
UF Health Shands Children's Hospital, Gainesville, FL, USA.
[17]
Department of Medicine, Division of Cell Therapy and Hematology, Duke University Medical Center, Durham, NC, USA.
[18]
CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.;Department of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
[19]
Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
[20]
Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
[21]
Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA.
[22]
Beth Israel Deaconess Medical Center, Westwood, KS, USA.
[23]
Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
[24]
Division of Hematology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
[25]
Division of Hematology and Oncology, University of Florida College of Medicine, Gainesville, FL, USA.
[26]
The Children's Hospital at TriStar Centennial and Sarah Cannon Research Institute, Nashville, TN, USA.
[27]
Texas Transplant Institute, San Antonio, TX, USA.
[28]
Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.
[29]
Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, KS, USA.
[30]
Yale New Haven Hospital, New Haven, CT, USA.
[31]
Department of Medicine, Division of Hematology and Oncology, Stem Cell Transplant Program-Loyola University Stritch School of Medicine, Maywood, IL, USA.
[32]
Center for Cell and Gene Therapy, Division of Hematology and Oncology, Baylor College of Medicine, Houston, TX, USA.
[33]
Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[34]
UT Southwestern Medical Center-BMT Program, Dallas, TX, USA.
[35]
Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
[36]
University of Louisville Hospital/James Brown Cancer Center, Louisville, KY, USA.
[37]
University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
[38]
Division of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
[39]
Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
[40]
Memorial Sloan Kettering Cancer Center-Adults, New York, NY, USA.
[41]
University of Chicago Medicine, Chicago, IL, USA.
[42]
University of Kansas, Westwood, KS, USA.
[43]
Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
[44]
Rush University Medical Center, Chicago, IL, USA.
[45]
Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.;Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
[46]
Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
[47]
University Hospital Basel, Basel, Switzerland.
[48]
Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand.
[49]
Translational Cell Therapy Group, CLINTEC (Clinical Science, Intervention and Technology), Karolinska Institutet, Stockholm, Sweden.
[50]
Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.
[51]
Penn State Hershey Medical Center, Hershey, PA, USA.
[52]
Tom Baker Cancer Centre, Calgary, AB, Canada.
[53]
Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
[54]
Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
[55]
Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.
[56]
The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA, USA.
[57]
Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
[58]
Maastricht University Medical Centre, Maastricht, The Netherlands.
[59]
Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands.
[60]
Blood & Marrow Transplantation Program, Department of Medicine, Division of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
[61]
Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.;CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN, USA.
[62]
Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
[63]
DOI
10.1038/s41409-021-01353-3
PMID
34017072
发布时间
2022-03-27
基金项目
U24 CA076518/CA/NCI NIH HHS/United States
UL1 TR001863/TR/NCATS NIH HHS/United States
- 浏览6
Bone marrow transplantation
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
